Isracann Biosciences
(OTC) ISCNF
Isracann Biosciences Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$4.54M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-348.48 (Low)
Dividend
$0.00
Beta (Volatility)
-348.48 (Low)
Price
$0.00
Volume
130,300
Open
$0.00
Price
$0.00
Volume
130,300
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-348.48 (Low)
Price
$0.00
Volume
130,300
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
ISCNF News
ISCNF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Isracann Biosciences
Industry
Pharmaceuticals
Sector
Health CareCEO
Philippe Floucault
Website
www.isracann.comHeadquarters
Vancouver, BC V7X 1L3, CA
ISCNF Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-0%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
130.30K
Short Interest
0.00%
Avg. Volume
17.68K
Financials (TTM)
Gross Profit
$41.73K
Operating Income
$2.39M
EBITDA
$2.39M
Operating Cash Flow
$1.75M
Capital Expenditure
$0.00
Free Cash Flow
$1.75M
Cash & ST Invst.
$213.94K
Total Debt
$0.00
Isracann Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$10.43K
+0.0%
Gross Margin
0.00%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$316.00K
+32.6%
EBITDA
$305.56K
+31.2%
Quarterly Fundamentals
Net Cash
$198.05K
-85.8%
Accounts Receivable
$83.21K
-14.9%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.15%
N/A
Return on Invested Capital
-0.08%
N/A
Free Cash Flow
$163.40K
+63.1%
Operating Cash Flow
$163.40K
+63.1%